Consun Pharmaceutical Group Limited (01681) maintained 847,983,407 issued ordinary shares as of 26 November 2025, with no change from the previous day. The company repurchased 131,000 shares on the same day, at prices ranging from HKD 14.92 to HKD 14.97, for an aggregate consideration of HKD 1,957,270.
Between 14 October 2025 and 26 November 2025, the company repurchased a cumulative total of 11,322,000 shares, equivalent to approximately 13.3002% of the issued share capital as of the date of the related resolution. While the repurchased shares are intended for cancellation, they have not yet been canceled as of 26 November 2025. The company confirmed that these transactions complied with the applicable listing rules and relevant regulatory requirements.
Comments